Granulocyte functions are independent of arginine availability

Journal of Leukocyte Biology

Volumn 96, Issue 6, 2014, Pages 1047-1053

  Kapp, Katharina ^a,b   Prüfer, Steve ^c   Michel, Christian S ^c   Habermeier, Alice ^c   Luckner Minden, Claudia ^c   Giese, Thomas ^a   Bomalaski, John ^d   Langhans, Claus Dieter ^b   Kropf, Pascale ^e   Müller, Ingrid ^e   Closs, Ellen I ^c   Radsak, Markus P ^c   Munder, Markus ^b,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d Polaris Pharmaceuticals   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Arginase; Immunosuppression; Innate immunity; Neutrophil

Indexed keywords

ARGININE; INTERLEUKIN 8; PEGARGIMINASE; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; ARGINASE; CITRULLINE; HYDROLASE; MACROGOL DERIVATIVE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; BRAIN VENTRICLE PERITONEUM SHUNT; CELL ACTIVATION; CELL VIABILITY; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRANULATION; EFFECTOR CELL; FLOW CYTOMETRY; FUNGICIDAL ACTIVITY; GRANULOCYTE FUNCTION; HUMAN; HUMAN CELL; INVASIVE ASPERGILLOSIS; MOUSE; MOUSE MODEL; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIMARY CELL; RESPIRATORY BURST; UPREGULATION; ANIMAL; APOPTOSIS; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LUNG; LUNG ASPERGILLOSIS; LUNG LAVAGE; METABOLISM; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; PRIMARY CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARGINASE; ARGININE; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CITRULLINE; HUMANS; HYDROLASES; IMMUNITY, INNATE; INTERLEUKIN-8; LUNG; MICE; MICE, INBRED C57BL; NEUTROPHILS; PHAGOCYTOSIS; POLYETHYLENE GLYCOLS; PRIMARY CELL CULTURE; PULMONARY ASPERGILLOSIS; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST;

EID: 84914161864     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3AB0214-082R     Document Type: Article

References (38)

1. Borregaard, N. (2010) Neutrophils, from marrow to microbes. Immunity 33, 657-670.
2. Mantovani, A., Cassatella, M. A., Costantini, C., Jaillon, S. (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11, 519-631.
3. Mocsai, A. (2013) Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J. Exp. Med. 210, 1283-1299.
4. Munder, M., Mollinedo, F., Calafat, J., Canchado, J., Gil-Lamaignere, C., Fuentes, J. M., Luckner, C., Doschko, G., Soler, G., Eichmann, K., Muller, F. M., Ho, A. D., Goerner, M., Modolell, M. (2005) Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105, 2549-2556.
5. Brandau, S., Moses, K., Lang, S. (2013) The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins? Semin. Cancer Biol. 23, 171-182.
6. Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., Ochoa, A. C. (2009) Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 69, 1553-1560.
7. Sippel, T. R., White, J., Nag, K., Tsvankin, V., Klaassen, M., Kleinschmidt-De-Masters, B. K., Waziri, A. (2011) Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clin. Cancer Res. 17, 6992-7002.
8. Mussai, F., De Santo, C., Abu-Dayyeh, I., Booth, S., Quek, L., McEwen-Smith, R. M., Qureshi, A., Dazzi, F., Vyas, P., Cerundolo, V. (2013) Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment. Blood 122, 749-758.
9. Brandau, S., Dumitru, C. A., Lang, S. (2013) Protumor and antitumor functions of neutrophil granulocytes. Semin. Immunopathol. 35, 163-176.
10. Bronte, V., Zanovello, P. (2005) Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5, 641-654.
11. Gabrilovich, D. I., Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174.
12. Munder, M., Schneider, H., Luckner, C., Giese, T., Langhans, C. D., Fuentes, J. M., Kropf, P., Mueller, I., Kolb, A., Modolell, M., Ho, A. D. (2006) Suppression of T-cell functions by human granulocyte arginase. Blood 108, 1627-1634.
13. Munder, M. (2009) Arginase: an emerging key player in the mammalian immune system. Br. J. Pharmacol. 158, 638-651.
14. Feldmeyer, N., Wabnitz, G., Leicht, S., Luckner-Minden, C., Schiller, M., Franz, T., Conradi, R., Kropf, P., Muller, I., Ho, A. D., Samstag, Y., Munder, M. (2012) Arginine deficiency leads to impaired cofilin dephosphorylation in activated human T lymphocytes. Int. Immunol. 24, 303-313.
15. Morris, S. M., Jr. (2012) Arginases and arginine deficiency syndromes. Curr. Opin. Clin. Nutr. Metab. Care 15, 64-70.
16. Kuo, M. T., Savaraj, N., Feun, L. G. (2010) Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes. Oncotarget 1, 246-251.
17. Feun, L. G., Marini, A., Walker, G., Elgart, G., Moffat, F., Rodgers, S. E., Wu, C. J., You, M., Wangpaichitr, M., Kuo, M. T., Sisson, W., Jungbluth, A. A., Bomalaski, J., Savaraj, N. (2012) Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. Br. J. Cancer 106, 1481-1485.
18. Ott, P. A., Carvajal, R. D., Pandit-Taskar, N., Jungbluth, A. A., Hoffman, E. W., Wu, B. W., Bomalaski, J. S., Venhaus, R., Pan, L., Old, L. J., Pavlick, A. C., Wolchok, J. D. (2013) Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma. Invest. New Drugs 31, 425-434.
19. Glazer, E. S., Piccirillo, M., Albino, V., Di Giacomo, R., Palaia, R., Mastro, A. A., Beneduce, G., Castello, G., De Rosa, V., Petrillo, A., Ascierto, P. A., Curley, S. A., Izzo, F. (2010) Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma. J. Clin. Oncol. 28, 2220-2226.
20. Luckner-Minden, C., Fischer, I., Langhans, C. D., Schiller, M., Kropf, P., Muller, I., Hohlfeld, J. M., Ho, A. D., Munder, M. (2010) Human eosinophil granulocytes do not express the enzyme arginase. J. Leukoc. Biol. 87, 1125-1132.
21. Oberlies, J., Watzl, C., Giese, T., Luckner, C., Kropf, P., Muller, I., Ho, A. D., Munder, M. (2009) Regulation of NK cell function by human granulocyte arginase. J. Immunol. 182, 5259-5267.
22. Prufer, S., Weber, M., Stein, P., Bosmann, M., Stassen, M., Kreft, A., Schild, H., Radsak, M. P. (2013) Oxidative burst and neutrophil elastase contribute to clearance of Aspergillus fumigatus pneumonia in mice. Immunobiology 219, 87-96.
23. Wagner, C., Iking-Konert, C., Hug, F., Stegmaier, S., Heppert, V., Wentzensen, A., Hansch, G. M. (2006) Cellular inflammatory response to persistent localized Staphylococcus aureus infection: phenotypical and functional characterization of polymorphonuclear neutrophils (PMN). Clin. Exp. Immunol. 143, 70-77.
24. Brenneis, H., Schmidt, A., Blaas-Mautner, P., Worner, I., Ludwig, R., Hansch, G. M. (1993) Chemotaxis of polymorphonuclear neutrophils (PMN) in patients suffering from recurrent infection. Eur. J. Clin. Invest. 23, 693-698.
25. Kahle, N. A., Brenner-Weiss, G., Overhage, J., Obst, U., Hansch, G. M. (2013) Bacterial quorum sensing molecule induces chemotaxis of human neutrophils via induction of p38 and leukocyte specific protein 1 (LSP1). Immunobiology 218, 145-151.
26. Weber, M., Lupp, C., Stein, P., Kreft, A., Bopp, T., Wehler, T. C., Schmitt, E., Schild, H., Radsak, M. P. (2013) Mechanisms of cyclic nucleotide phosphodiesterases in modulating T cell responses in murine graft-versus-host disease. PLoS One 8, e58110.
27. Simon, A., Karbach, S., Habermeier, A., Closs, E. I. (2013) Decoding the substrate supply to human neuronal nitric oxide synthase. PLoS One 8, e67707.
28. Cassatella, M. A. (1999) Neutrophil-derived proteins: selling cytokines by the pound. Adv. Immunol. 73, 369-509.
29. Grohmann, U., Bronte, V. (2010) Control of immune response by amino acid metabolism. Immunol. Rev. 236, 243-264.
30. Modolell, M., Choi, B. S., Ryan, R. O., Hancock, M., Titus, R. G., Abebe, T., Hailu, A., Muller, I., Rogers, M. E., Bangham, C. R., Munder, M., Kropf, P. (2009) Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis. PLoS Negl. Trop. Dis. 3, e480.
31. Cloke, T. E., Garvey, L., Choi, B. S., Abebe, T., Hailu, A., Hancock, M., Kadolsky, U., Bangham, C. R., Munder, M., Muller, I., Taylor, G. P., Kropf, P. (2010) Increased level of arginase activity correlates with disease severity in HIV-seropositive patients. J. Infect. Dis. 202, 374-385.
32. Maarsingh, H., Zaagsma, J., Meurs, H. (2008) Arginine homeostasis in allergic asthma. Eur. J. Pharmacol. 585, 375-384.
33. Muller, I., Munder, M., Kropf, P., Hansch, G. M. (2009) Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends Immunol. 30, 522-530.
34. Thewissen, M., Damoiseaux, J., van de Gaar, J., Tervaert, J. W. (2011) Neutrophils and T cells: bidirectional effects and functional interferences. Mol. Immunol. 48, 2094-2101.
35. Rotondo, R., Bertolotto, M., Barisione, G., Astigiano, S., Mandruzzato, S., Ottonello, L., Dallegri, F., Bronte, V., Ferrini, S., Barbieri, O. (2011) Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation. J. Leukoc. Biol. 89, 721-727.
36. Schmielau, J., Finn, O. J. (2001) Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res. 61, 4756-4760.
37. Pillay, J., Kamp, V. M., van Hoffen, E., Visser, T., Tak, T., Lammers, J. W., Ulfman, L. H., Leenen, L. P., Pickkers, P., Koenderman, L. (2012) A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J. Clin. Invest. 122, 327-336.
38. Munder, M., Engelhardt, M., Knies, D., Medenhoff, S., Wabnitz, G., Luckner-Minden, C., Feldmeyer, N., Voss, R. H., Kropf, P., Muller, I., Conradi, R., Samstag, Y., Theobald, M., Ho, A. D., Goldschmidt, H., Hundemer, M. (2013) Cytotoxicity of tumor antigen specific human T cells is unimpaired by arginine depletion. PLoS One 8, e63521.